"The Know" is an informational resource concerning vein treatment options. It contains valuable information for prospective patients, physicians as well as those in the vein treatment industry. We will be regularly posting educational articles, video logs and other pertinent information. We encourage your feedback and welcome any suggestions that you feel may improve the blog.
|
Tuesday, May 31, 2011
|
|
Dr. Lowell Kabnick Completes Medical Mission Trip to Vietnam
|
World-renowned surgeon-teacher visits Vietnam providing clinical treatment to patients in need of venous intervention. Dr. Lowell S. Kabnick, MD, FACS, FACPh, an internationally recognized leader in the diagnosis and treatment of venous disease, recently traveled to Vietnam on a medical mission trip to provide vitally needed care to patients with vein disease.
While a strong emphasis of the trip was in providing patient care, Dr. Kabnick was also excited to offer an educational opportunity to the knowledgeable, but financially under-supported local health care professionals. In addition to providing care during his trip, Dr. Kabnick presented a lecture entitled "What We Know about Endothermal Ablation of the Saphenous Trunk," in Hanoi, which was translated in advance for Vietnamese physicians.
Having grown up in the area, and possessing strong ties to the history and culture of Vietnam, Dr. Kabnick stressed what a valuable and personally touching experience this trip was. Kabnick stated, "You almost do not even realize how much something like this means. The Vietnamese people were warm and hospitable."
Very much aware of the fact that a short term medical mission will not address the largest health care needs in Vietnam, Dr. Kabnick's hope is that his efforts will contribute toward alleviating some of these needs.
About Lowell S. Kabnick, MD, FACS
Lowell S. Kabnick, M.D., FACS, FACPh, Director of NYU Vein Center, is a world-renowned surgeon-teacher whose patient-centered approach to vein care has enabled the creation and improvement of many of today's most advanced noninvasive vascular surgery techniques. Recognized by his peers as an international authority on the diagnosis and treatment of venous disease, Dr. Kabnick was the first vascular surgeon in the United States to perform the VNUS Closure™ (radiofrequency) procedure and the VenaCure EVLT™ (laser) procedure--two FDA approved breakthrough technologies for treating the underlying causes of many varicose vein problems. Because of Dr. Kabnick's achievements, and his reputation as a personable and scholarly caregiver, he not only attracts patients locally, but also nationally and internationally.
|
|
|
Friday, January 28, 2011
|
|
Renowned Expert from Nationally-Recognized Medical Center Writes Patient’s Reference Guide on Venous Disease
|
Venous disease affects 50-80 million people in the United States and translates to over $1 billion dollars in lost employee productivity. After all, how can you stand or sit at work with unhealthy legs, poor circulation, or pressure on the nerves?
Varicose Veins…A Patient’s Reference is the first reference guide developed specifically to enhance a patient’s understanding of the causes, symptoms and treatment options for venous disorders. It is written for potential vein patients in a language they can understand and provides insight that they can apply on their first visit with the doctor of their choice. The content of the book encompasses all treatments of venous disease in various stages, with a variety of medical treatment options for various types and stages of venous disease.
Take the first step in regaining quality of life for yourself or a loved one by purchasing Varicose Veins…A Patient’s Reference, and seeking treatment from a trained physician who specializes in the treatment of venous disease in your area. Order your copy today by contacting the publisher at (877) 613-2665 or publishing@e-booktime.com.
Readers who do not live in Arizona, New Mexico or Texas, but are interested in visiting The Center for Venous Disease, our doctors offer a Fly-In and Fly-Out program at any of our CVD offices located in Arizona, New Mexico, and Texas. For more information on Center for Venous Disease, please call (623) 234-2542.
###
ABOUT THE CENTER FOR VENOUS DISEASE
The Center for Venous Disease (CVD) was established with the patient in mind and a singular mission: “Treat your symptoms and touch your Heart.” CVD is focused on a TOTAL VEIN CARE philosophy utilizing state-of-the-art technology with Board Certified Doctors. CVD’s Medical Directors are double- or triple-board-certified, including Phlebology (vein specialty), and utilize only FDA-approved drugs and FDA-cleared devices. CVD is a nationally recognized training facility for the VNUS Closure™ procedure for varicose vein treatment, and is the highest volume vein treatment center in the Southwest United States. This expertise sets CVD apart from other offices or hospitals who have added vein care to an existing practice that is focused on other medical conditions or specialties. For more information on Center for Venous Disease, please call (623) 234-2542.
|
|
|
Friday, January 28, 2011
|
|
Covidien Announces New Evidence that Demonstrates Clinical Efficacy of VNUS ClosureFAST Catheter
|
Multicenter Study Results Presented at 37th Annual VEITH Symposium
Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that results from a prospective, multicenter study using the VNUS ClosureFAST(TM) catheter, demonstrated clinical efficacy and improvement in quality of life for patients. The ClosureFAST catheter is an endovenous radiofrequency (RF) ablation catheter designed to heat and close diseased veins, the major underlying cause of varicose veins.
The results were presented at the American College of Phlebology's 24th Annual Congress in Orlando, Florida on November 5, and here today at the 37th Annual VEITH Symposium on Vascular and Endovascular Issues.
Alan Dietzek, M.D., Chief of Vascular Surgery and the Linda and Stephen R. Cohen Chair in Vascular Surgery at Danbury Hospital in Connecticut, presented three-year follow-up results of patients treated with the ClosureFAST catheter from a study conducted at 13 centers in the U.S. and Europe. Two-hundred sixty-seven greater saphenous veins were evaluated at the follow-up and demonstrated a 93% occlusion rate using Kaplan-Meier analysis.
In addition to clinical efficacy, the study has shown a venous clinical severity score reduction at three-year follow up, which indicates an improvement in patients' relief of symptoms, such as pain or inflammation, from the baseline score at time of treatment.
These results were consistent with those presented this month for the seven European study sites by
Professor Thomas M. Proebstle, M.D., PhD, of the Department of Dermatology, University of Mainz, Germany, and the University of Pécs, Hungary, in his presentation titled, "Three Year Follow-Up After Radiofrequency Segmental Thermal Ablation of Great Saphenous Veins." The European study was presented at the American College of Phlebology.
"These study results continue to support and strengthen clinicians' confidence in the ClosureFAST technology and its effectiveness in treating millions of venous insufficiency patients who suffer from varicose veins," said Joe Woody, President, Vascular Therapies, Covidien.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has approximately 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries.
|
|
|
Thursday, July 30, 2009
|
|
VNUS Makes Removal Quick
|
The VNUS closure procedure makes removing harmful and painful varicose veins quicker and easier than ever. Those suffering from varicose veins say they feel heaviness to their legs and perhaps fatigue. Once the procedure is complete, these symptoms usually disappear. The procedure takes about 15 minutes and uses a small incision hole, in comparison to traditional surgical treatments that are more invasive.
"Doctors say think of the vein system as a traffic map. When one freeway is faulty and the bloods not traveling efficiently the answer here is to shut it down" reports ABC News. Surrounding veins will take up the responsibilities of the diseased vein that is removed. The procedure is covered by most insurance companies and is growing in popularity due to the efficiency of treatment.
|
|
|
Thursday, June 25, 2009
|
|
Minimally Invasive Surgeries go Abroad
|
Minimally invasive procedures like radiofrequency, VNUS and endovenous laser removal have all been readily accessible and used in the United States. Now such procedures are heading overseas to China. The numbers in China are far greater than that of the US, 100 million in China suffer from varicose veins and spider veins. In fact the minimally invasive charge is heading into the Asian market with full force; trained vascular surgeons will be training Chinese based physicians on such techniques.
China Daily said, "The hospital is cooperating with InaVein Llc and VNUS Inc from the United States, as well as Diomed Inc from the United Kingdom, to set up the TriVex, RFO (radiofrequency endoveous occlusion) and EVLT (endovenous laser treatment) training centers. It will hold the first training class on minimally invasive treatment for 193 doctors, mainly from northern China."
The training sessions will hopefully spread into the greater Asian region.
|
|
|
Thursday, June 18, 2009
|
|
Covidien and VNUS Buyout
|
Covidien the medical device maker and healthcare company has announced they have completed their buyout of VNUS Medical Technologies for $440 million. VNUS is a San Jose based company that makes products for treating varicose veins. Covidien has said they are hoping to expand their presence in the venous disease market and buying VNUS is part of their expansion strategy.
CNBC said, "The acquisition of VNUS will expand our vascular product line and is consistent with our strategy of becoming a leading partner with interventional radiologists and vascular surgeons," said Joe Almeida, president of medical devices for Covidien, in a statement Wednesday."
The venous disease treatment industry is said to be dramatically expanding due to innovation in technologies and demand from the 40 million people with varicose veins. It is a lucrative market to be involved in at the moment.
|
|
|
Tuesday, June 09, 2009
|
|
Radiofrequency and Varicose Veins
|
Recent numbers have been released by Medical Technologies, the company which has developed VNUS Closure Fast treatment for varicose veins that the number of patients using the technique has increased to 500,000 globally. From the United States to Europe the procedure is readily used for varicose vein removal. Millions of people worldwide suffer from gnarled and ropy venous disease, which has the potential to lead to more threatening ailments like Deep Vein Thrombosis (DVT).
A press release from PR News Wire said, "VNUS solutions have also achieved widespread acceptance among medical insurers, with all major US health insurance insurers covering radiofrequency vein ablation for patients with symptomatic varicose veins and venous reflux. In addition, the VNUS procedure is available in 40 countries and is covered by the national health insurance systems in the UK and France."
The procedure aids in removal and promotes circulation and blood flow through the veins. Patients, physicians and Medical Technologies is thrilled at the prospect of this technology, especially considering it has the potential to treat millions of patients plagued with such discomfort in their legs and veins.
|
|
|
Monday, May 11, 2009
|
|
Covidien Spreading
|
Covidien Ltd has reported to the Associated Press that it plans to purchase
VNUS Medical Technologies for $440 million which Covidien believes will be
completed by the end of June. The varicose vein and venous disease industry
is said to be dramatically increasing as minimally invasive techniques and
procedures become more innovative, effective and cost efficient.
Forbes reported on the purchase saying, "San Jose, Calif.-based VNUS makes
products that treat varicose veins and venous reflux disease, a circulatory
condition that causes blood to pool in the veins of the leg. That can cause
swollen veins and discolored skin. Covidien said it is expanding its
vascular business by buying VNUS, and it will make VNUS part of its vascular
product line."
Similarly, VNUS is considered to be one of the most reputable firms in the
industry of varicose vein removal. As the industry begins to spread and
grow, many advocates for prevention hope that awareness about the diseases
and treatments will also boost.
|
|
|
Tuesday, February 24, 2009
|
|
Baby Boomer Vein Surgeries Booming
|
A popular trend in the baby boomer demographic at the moment is varicose vein and venous disease related surgeries. As our baby boomer population begins to age, their health begins to deteriorate. One common ailment is varicose veins and Deep Vein Thrombosis (DVT). After years of standing, sitting at work for long hours and traveling in the air, many of these people are vulnerable and susceptible to such vein health issues.
Luckily treatments like VNUS ClosureFast and Radio Frequency Occlusion have been easier, more cost efficient and less painful as opposed to former painful stripping techniques. Traditional techniques involved long recovery times, high costs and required anaesthesia. These new and improved removal procedures are booming among ailing baby-boomers.
|
|
|
Tuesday, February 17, 2009
|
|
Technology and Popularity
|
As technology begins to improve in the vein industry so too does the popularity and awareness of venous disease. From news stations to newspapers, media organizations, physicians and people are becoming savvy and knowledgeable about the methods available to treat and prevent varicose veins and spider veins. From SIVGARIS vein health conventions to gabbing about the unsightly ailments with friends, more people are learning how to keep their legs and veins healthy.
Laser removal and stripping techniques have become so advanced and efficient that they too are making headlines. From VNUS Closure Fast to Radio Frequency Occlusion, their are a large number of ways to remove varicose veins. The traditional method of invasive stripping has become completly obselete whilst there remain to be many industry ubiquitous hype surrounding some prevention methods and removal techniques. Stick to the few main treatments highlighted on veindirectory.org and read the papers for new updates in the sector.
|
|
|
|
|
|
